A REVIEW OF COMMON PLANTS USED IN THE TREATMENT OF TYPHOID FEVER: ACTIVE COMPONENTS AND TOXICITY RELATED ISSUES

Cite this:
[1]
T. AKWA, “A REVIEW OF COMMON PLANTS USED IN THE TREATMENT OF TYPHOID FEVER: ACTIVE COMPONENTS AND TOXICITY RELATED ISSUES”, ijmhs, vol. 11, no. 4 (July- Aug), Jul. 2021.
© 2022 Interactive Protocols
RIGHTS & PERMISSIONS
Article Views
279
Altmetric
1
Citations
-
LEARN ABOUT THESE METRICS
   PDF      XML      E-PUB  

Abstract

Majority of plants and their extracts are a primary source of health care in most communities. The usage of plants in the treatment of diseases has been observed in ancient times and still applicable in the present. Plants extracts are used due to their easy availability and affordability. Some of these extracts are being sold locally in markets while others manufactured and used in household settings. Most often, the producers of these extracts do not show proof of safety and efficacy before marketing these products. Consequently, the negative effects and the downside following the consumption of these products remain unknown. Moreover, the plant extracts are not regulated for purity and potency. Impurities present and the potency of the plant products might also contribute significantly to adverse effects following consumption. In most developing countries especially Africa, traditional methods involving plant extracts have mostly been employed in the treatment of typhoid fever. Even though the extracts from these plants have proven to be efficient in the treatment of typhoid, there’s currently not enough evidence to make precise dosage recommendations for each of the common plant products. This document reviews the common plants used in the treatment of typhoid fever, their active components and the toxicity related issue following their indiscriminate consumption. Knowledge of the risk and toxicity effects will lead to the control of the usage of the product by consumers. There is however a need to subject the extracts from these plants to further studies so as to effectively standardize the safe dose needed in the treatment of this disease.

KEYWORDS:

 Special Issue

Article Metrics Graph

Chart Graph | Range Graph

Content

Section

Source

License

All paper submissions must carry the following duly signed by all the authors:
“I certify that I have participated sufficiently in the conception and design of this work and the analysis of the data (wherever applicable), as well as the writing of the manuscript, to take public responsibility for it. I believe the manuscript represents valid work. I have reviewed the final version of the manuscript and approve it for publication. Neither has the manuscript nor one with substantially similar content under my authorship been published nor is being considered for publication elsewhere, except as described in an attachment. Furthermore I attest that I shall produce the data upon which the manuscript is based for examination by the editors or their assignees, if requested.”